| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Panax | 59 | 2024 | 171 | 9.910 |
Why?
|
| Plant Extracts | 68 | 2022 | 247 | 9.460 |
Why?
|
| Phytotherapy | 39 | 2023 | 137 | 6.430 |
Why?
|
| Ginsenosides | 44 | 2024 | 124 | 5.370 |
Why?
|
| Antineoplastic Agents, Phytogenic | 27 | 2018 | 270 | 5.200 |
Why?
|
| Colonic Neoplasms | 13 | 2024 | 579 | 4.240 |
Why?
|
| Drugs, Chinese Herbal | 27 | 2023 | 68 | 3.420 |
Why?
|
| Oplopanax | 17 | 2021 | 29 | 3.310 |
Why?
|
| Flavonoids | 21 | 2020 | 85 | 3.150 |
Why?
|
| Colorectal Neoplasms | 34 | 2019 | 1054 | 3.060 |
Why?
|
| Apoptosis | 42 | 2024 | 1719 | 2.840 |
Why?
|
| Flavanones | 12 | 2020 | 35 | 2.780 |
Why?
|
| Chromatography, High Pressure Liquid | 33 | 2021 | 304 | 2.630 |
Why?
|
| Cell Proliferation | 36 | 2024 | 1735 | 2.250 |
Why?
|
| Gastrointestinal Microbiome | 12 | 2022 | 590 | 2.110 |
Why?
|
| Sapogenins | 10 | 2019 | 25 | 2.000 |
Why?
|
| Panax notoginseng | 8 | 2017 | 23 | 1.970 |
Why?
|
| Antioxidants | 17 | 2019 | 231 | 1.900 |
Why?
|
| Molecular Imprinting | 13 | 2022 | 13 | 1.640 |
Why?
|
| Saponins | 14 | 2022 | 41 | 1.580 |
Why?
|
| Scutellaria baicalensis | 12 | 2021 | 26 | 1.580 |
Why?
|
| Artemisinins | 2 | 2024 | 6 | 1.540 |
Why?
|
| Fluorouracil | 8 | 2015 | 524 | 1.490 |
Why?
|
| Anticarcinogenic Agents | 5 | 2013 | 71 | 1.480 |
Why?
|
| Fruit | 11 | 2021 | 81 | 1.430 |
Why?
|
| Cell Cycle | 20 | 2021 | 515 | 1.400 |
Why?
|
| Plant Roots | 25 | 2017 | 112 | 1.370 |
Why?
|
| Anti-Inflammatory Agents | 9 | 2020 | 353 | 1.250 |
Why?
|
| Colitis | 6 | 2018 | 261 | 1.220 |
Why?
|
| Neoplasms | 11 | 2018 | 3171 | 1.210 |
Why?
|
| Cell Line, Tumor | 35 | 2018 | 2756 | 1.170 |
Why?
|
| Glucosides | 4 | 2020 | 16 | 1.150 |
Why?
|
| Animals | 102 | 2024 | 28041 | 1.140 |
Why?
|
| Cytokines | 11 | 2024 | 863 | 1.040 |
Why?
|
| Mass Spectrometry | 13 | 2021 | 198 | 1.040 |
Why?
|
| HCT116 Cells | 20 | 2024 | 162 | 1.020 |
Why?
|
| Tandem Mass Spectrometry | 9 | 2022 | 108 | 1.020 |
Why?
|
| Chemoprevention | 7 | 2022 | 93 | 1.010 |
Why?
|
| Medicine, Chinese Traditional | 3 | 2020 | 9 | 1.000 |
Why?
|
| Daphne | 8 | 2020 | 9 | 0.950 |
Why?
|
| Catechols | 2 | 2015 | 8 | 0.920 |
Why?
|
| Polymers | 9 | 2021 | 218 | 0.910 |
Why?
|
| Molecular Docking Simulation | 5 | 2021 | 57 | 0.900 |
Why?
|
| Carcinogenesis | 3 | 2017 | 235 | 0.890 |
Why?
|
| Humans | 107 | 2024 | 93615 | 0.850 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2024 | 4 | 0.830 |
Why?
|
| Antineoplastic Agents | 15 | 2024 | 2302 | 0.820 |
Why?
|
| Complementary Therapies | 2 | 2024 | 53 | 0.810 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2020 | 291 | 0.790 |
Why?
|
| Mice | 42 | 2024 | 12233 | 0.790 |
Why?
|
| Antimetabolites, Antineoplastic | 4 | 2015 | 244 | 0.780 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2020 | 109 | 0.780 |
Why?
|
| Naltrexone | 4 | 2013 | 139 | 0.760 |
Why?
|
| Narcotic Antagonists | 4 | 2013 | 170 | 0.750 |
Why?
|
| Neuroprotective Agents | 3 | 2019 | 98 | 0.740 |
Why?
|
| Inflammation | 6 | 2021 | 1049 | 0.720 |
Why?
|
| Migraine Disorders | 5 | 2021 | 41 | 0.690 |
Why?
|
| Rats | 31 | 2022 | 4042 | 0.670 |
Why?
|
| Breast Neoplasms | 7 | 2013 | 3158 | 0.660 |
Why?
|
| Disease Models, Animal | 24 | 2021 | 2491 | 0.660 |
Why?
|
| Colon | 6 | 2019 | 540 | 0.640 |
Why?
|
| Vitis | 3 | 2011 | 19 | 0.630 |
Why?
|
| Ultrafiltration | 1 | 2019 | 11 | 0.610 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 3 | 2015 | 14 | 0.580 |
Why?
|
| NF-kappa B | 5 | 2020 | 408 | 0.570 |
Why?
|
| Diynes | 2 | 2021 | 7 | 0.560 |
Why?
|
| Fatty Alcohols | 2 | 2021 | 10 | 0.560 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2022 | 1243 | 0.560 |
Why?
|
| Structure-Activity Relationship | 9 | 2017 | 423 | 0.560 |
Why?
|
| Membrane Potential, Mitochondrial | 4 | 2018 | 32 | 0.550 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 454 | 0.540 |
Why?
|
| Antiemetics | 3 | 2015 | 28 | 0.540 |
Why?
|
| Intestine, Small | 1 | 2019 | 310 | 0.530 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2020 | 183 | 0.530 |
Why?
|
| Acute Disease | 1 | 2019 | 841 | 0.520 |
Why?
|
| Abdominal Pain | 1 | 2018 | 143 | 0.520 |
Why?
|
| Hypoglycemic Agents | 6 | 2021 | 379 | 0.510 |
Why?
|
| Arthritis, Experimental | 4 | 2019 | 26 | 0.500 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2019 | 45 | 0.500 |
Why?
|
| Biological Products | 4 | 2014 | 178 | 0.490 |
Why?
|
| Critical Illness | 1 | 2019 | 343 | 0.490 |
Why?
|
| Dose-Response Relationship, Drug | 16 | 2017 | 1913 | 0.480 |
Why?
|
| Cyclin A | 5 | 2021 | 27 | 0.480 |
Why?
|
| Chromatography, Liquid | 9 | 2022 | 102 | 0.480 |
Why?
|
| Vomiting | 6 | 2012 | 108 | 0.480 |
Why?
|
| Cell Cycle Checkpoints | 5 | 2021 | 68 | 0.470 |
Why?
|
| Stomach Ulcer | 4 | 2016 | 23 | 0.470 |
Why?
|
| Anti-Ulcer Agents | 4 | 2016 | 22 | 0.470 |
Why?
|
| Male | 59 | 2021 | 44578 | 0.460 |
Why?
|
| Catechin | 2 | 2012 | 22 | 0.460 |
Why?
|
| Herbal Medicine | 3 | 2017 | 8 | 0.460 |
Why?
|
| HT29 Cells | 6 | 2024 | 49 | 0.460 |
Why?
|
| cdc25 Phosphatases | 1 | 2015 | 19 | 0.460 |
Why?
|
| Polyphenols | 3 | 2012 | 13 | 0.460 |
Why?
|
| Nitroglycerin | 4 | 2020 | 24 | 0.450 |
Why?
|
| CDC2 Protein Kinase | 1 | 2015 | 46 | 0.450 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 76 | 0.450 |
Why?
|
| Dextran Sulfate | 5 | 2018 | 70 | 0.440 |
Why?
|
| Solid Phase Extraction | 7 | 2020 | 14 | 0.440 |
Why?
|
| Metabolomics | 5 | 2022 | 98 | 0.440 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 353 | 0.430 |
Why?
|
| Mice, Nude | 7 | 2015 | 824 | 0.430 |
Why?
|
| Drug Discovery | 1 | 2015 | 113 | 0.430 |
Why?
|
| Nausea | 5 | 2012 | 93 | 0.430 |
Why?
|
| Constipation | 2 | 2022 | 66 | 0.420 |
Why?
|
| Drug Synergism | 12 | 2018 | 315 | 0.410 |
Why?
|
| Cell Death | 4 | 2013 | 253 | 0.410 |
Why?
|
| Boraginaceae | 1 | 2013 | 3 | 0.410 |
Why?
|
| Pica | 4 | 2007 | 14 | 0.410 |
Why?
|
| Flavones | 3 | 2019 | 4 | 0.410 |
Why?
|
| Naphthoquinones | 1 | 2013 | 8 | 0.400 |
Why?
|
| Glycoside Hydrolases | 1 | 2013 | 12 | 0.400 |
Why?
|
| Drug Contamination | 2 | 2014 | 12 | 0.400 |
Why?
|
| Azoxymethane | 4 | 2017 | 84 | 0.400 |
Why?
|
| Phenols | 3 | 2014 | 41 | 0.400 |
Why?
|
| Feces | 7 | 2020 | 360 | 0.390 |
Why?
|
| Molecular Structure | 11 | 2020 | 306 | 0.380 |
Why?
|
| Tea | 1 | 2012 | 19 | 0.380 |
Why?
|
| Hot Temperature | 5 | 2016 | 217 | 0.370 |
Why?
|
| Smilax | 3 | 2018 | 5 | 0.360 |
Why?
|
| Oseltamivir | 1 | 2012 | 9 | 0.360 |
Why?
|
| Reperfusion Injury | 2 | 2011 | 148 | 0.360 |
Why?
|
| Mitochondria | 2 | 2013 | 612 | 0.360 |
Why?
|
| Rheum | 2 | 2022 | 2 | 0.360 |
Why?
|
| Plants, Medicinal | 5 | 2022 | 39 | 0.350 |
Why?
|
| Adsorption | 9 | 2022 | 52 | 0.350 |
Why?
|
| Flow Cytometry | 6 | 2018 | 712 | 0.350 |
Why?
|
| Cisplatin | 5 | 2006 | 568 | 0.350 |
Why?
|
| Plant Stems | 3 | 2014 | 9 | 0.350 |
Why?
|
| Indans | 1 | 2011 | 37 | 0.340 |
Why?
|
| Plant Preparations | 3 | 2017 | 20 | 0.340 |
Why?
|
| Prescription Drugs | 1 | 2011 | 38 | 0.340 |
Why?
|
| Free Radical Scavengers | 6 | 2017 | 59 | 0.340 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 112 | 0.340 |
Why?
|
| Lipid Metabolism | 3 | 2021 | 214 | 0.330 |
Why?
|
| Publishing | 1 | 2012 | 91 | 0.330 |
Why?
|
| Steam | 2 | 2024 | 5 | 0.330 |
Why?
|
| Intestines | 4 | 2017 | 432 | 0.320 |
Why?
|
| Nitric Oxide | 7 | 2017 | 281 | 0.320 |
Why?
|
| Piperidines | 1 | 2011 | 165 | 0.320 |
Why?
|
| Principal Component Analysis | 3 | 2020 | 167 | 0.320 |
Why?
|
| Heterografts | 3 | 2015 | 116 | 0.300 |
Why?
|
| Coronary Disease | 1 | 2011 | 223 | 0.300 |
Why?
|
| Adenomatous Polyposis Coli Protein | 3 | 2019 | 42 | 0.300 |
Why?
|
| Caspases | 4 | 2013 | 151 | 0.290 |
Why?
|
| Wine | 2 | 2020 | 6 | 0.290 |
Why?
|
| Magnetite Nanoparticles | 2 | 2020 | 26 | 0.290 |
Why?
|
| Antiviral Agents | 1 | 2012 | 364 | 0.290 |
Why?
|
| Reishi | 2 | 2007 | 7 | 0.280 |
Why?
|
| Reactive Oxygen Species | 8 | 2022 | 502 | 0.280 |
Why?
|
| Influenza, Human | 1 | 2012 | 347 | 0.280 |
Why?
|
| Signal Transduction | 9 | 2022 | 3498 | 0.280 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 513 | 0.280 |
Why?
|
| Metabolome | 2 | 2022 | 62 | 0.280 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2019 | 91 | 0.270 |
Why?
|
| Curcumin | 2 | 2020 | 16 | 0.270 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2018 | 22 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 12 | 2022 | 3430 | 0.260 |
Why?
|
| Plant Leaves | 3 | 2006 | 86 | 0.260 |
Why?
|
| Phytochemicals | 2 | 2024 | 6 | 0.250 |
Why?
|
| Myocytes, Cardiac | 5 | 2017 | 313 | 0.250 |
Why?
|
| Up-Regulation | 3 | 2021 | 729 | 0.250 |
Why?
|
| Berberine Alkaloids | 2 | 2016 | 2 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2022 | 364 | 0.240 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2021 | 201 | 0.240 |
Why?
|
| Biological Availability | 3 | 2016 | 86 | 0.240 |
Why?
|
| Cyclins | 2 | 2021 | 80 | 0.230 |
Why?
|
| Alkaloids | 2 | 2016 | 47 | 0.230 |
Why?
|
| Mahonia | 2 | 2016 | 2 | 0.230 |
Why?
|
| Seeds | 1 | 2005 | 62 | 0.230 |
Why?
|
| Hydrogen Bonding | 2 | 2018 | 154 | 0.230 |
Why?
|
| Fritillaria | 1 | 2005 | 1 | 0.230 |
Why?
|
| DNA, Ribosomal Spacer | 1 | 2005 | 18 | 0.220 |
Why?
|
| DNA, Plant | 1 | 2005 | 45 | 0.220 |
Why?
|
| Drug Carriers | 2 | 2016 | 88 | 0.220 |
Why?
|
| Biotransformation | 3 | 2020 | 46 | 0.220 |
Why?
|
| Rats, Wistar | 7 | 2020 | 300 | 0.220 |
Why?
|
| Inflammation Mediators | 4 | 2020 | 159 | 0.210 |
Why?
|
| Tumor Cells, Cultured | 4 | 2017 | 1025 | 0.210 |
Why?
|
| Hyperuricemia | 2 | 2015 | 25 | 0.210 |
Why?
|
| Quaternary Ammonium Compounds | 4 | 2013 | 81 | 0.210 |
Why?
|
| Gene Expression | 3 | 2015 | 1302 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2016 | 526 | 0.210 |
Why?
|
| Ruthenium | 1 | 2024 | 5 | 0.210 |
Why?
|
| Coordination Complexes | 1 | 2024 | 20 | 0.200 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 400 | 0.200 |
Why?
|
| Cell Survival | 9 | 2020 | 1003 | 0.200 |
Why?
|
| Oxidative Stress | 5 | 2012 | 467 | 0.200 |
Why?
|
| Caspase 3 | 3 | 2018 | 161 | 0.190 |
Why?
|
| Plant Bark | 4 | 2018 | 5 | 0.190 |
Why?
|
| Administration, Oral | 6 | 2019 | 657 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 1231 | 0.190 |
Why?
|
| Cholesterol | 3 | 2017 | 364 | 0.190 |
Why?
|
| Cycloparaffins | 1 | 2022 | 5 | 0.190 |
Why?
|
| Diet, High-Fat | 3 | 2021 | 135 | 0.190 |
Why?
|
| Bacteria | 3 | 2017 | 509 | 0.190 |
Why?
|
| Female | 22 | 2020 | 48779 | 0.190 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 179 | 0.180 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 66 | 0.180 |
Why?
|
| Platycodon | 1 | 2022 | 1 | 0.180 |
Why?
|
| Scutellaria | 2 | 2017 | 3 | 0.180 |
Why?
|
| Antitussive Agents | 1 | 2022 | 3 | 0.180 |
Why?
|
| Expectorants | 1 | 2022 | 5 | 0.180 |
Why?
|
| Fermented Foods | 1 | 2021 | 1 | 0.180 |
Why?
|
| Monascus | 1 | 2021 | 2 | 0.180 |
Why?
|
| Bile | 2 | 2012 | 60 | 0.180 |
Why?
|
| Antirheumatic Agents | 2 | 2020 | 59 | 0.180 |
Why?
|
| Obesity | 5 | 2022 | 1019 | 0.180 |
Why?
|
| Pain | 2 | 2020 | 415 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2022 | 140 | 0.170 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 767 | 0.170 |
Why?
|
| Methylene Chloride | 1 | 2021 | 2 | 0.170 |
Why?
|
| Macrophages | 3 | 2020 | 610 | 0.170 |
Why?
|
| Isoflavones | 2 | 2018 | 13 | 0.170 |
Why?
|
| Tumor Burden | 2 | 2019 | 321 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 1339 | 0.160 |
Why?
|
| Caspase 9 | 2 | 2018 | 47 | 0.160 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 603 | 0.160 |
Why?
|
| Edema | 2 | 2018 | 70 | 0.160 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 1275 | 0.160 |
Why?
|
| Epimedium | 1 | 2020 | 1 | 0.160 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2020 | 30 | 0.160 |
Why?
|
| Sesquiterpenes | 1 | 2020 | 13 | 0.160 |
Why?
|
| DNA Methylation | 3 | 2022 | 697 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 1133 | 0.160 |
Why?
|
| Chitosan | 1 | 2020 | 17 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 78 | 0.160 |
Why?
|
| Glycyrrhiza | 1 | 2020 | 1 | 0.160 |
Why?
|
| Blood Glucose | 5 | 2014 | 868 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 261 | 0.160 |
Why?
|
| Flowers | 3 | 2014 | 41 | 0.160 |
Why?
|
| Electrochemical Techniques | 1 | 2020 | 6 | 0.160 |
Why?
|
| Neurosecretory Systems | 1 | 2020 | 35 | 0.160 |
Why?
|
| Acetic Acid | 2 | 2016 | 7 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 755 | 0.160 |
Why?
|
| Emodin | 2 | 2018 | 6 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 665 | 0.150 |
Why?
|
| Quantum Dots | 1 | 2019 | 19 | 0.150 |
Why?
|
| Vasodilator Agents | 2 | 2020 | 133 | 0.150 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 140 | 0.150 |
Why?
|
| Arthritis, Gouty | 1 | 2019 | 4 | 0.150 |
Why?
|
| Acupuncture Therapy | 1 | 2019 | 9 | 0.150 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2019 | 8 | 0.150 |
Why?
|
| Monoamine Oxidase | 1 | 2019 | 24 | 0.150 |
Why?
|
| alpha-Fetoproteins | 1 | 2019 | 45 | 0.150 |
Why?
|
| Menopause | 1 | 2020 | 87 | 0.150 |
Why?
|
| Biomimetic Materials | 1 | 2019 | 25 | 0.150 |
Why?
|
| Ligusticum | 2 | 2020 | 2 | 0.150 |
Why?
|
| Fluorescent Dyes | 2 | 2019 | 256 | 0.150 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 555 | 0.150 |
Why?
|
| Longevity | 1 | 2019 | 60 | 0.150 |
Why?
|
| Temperature | 2 | 2018 | 423 | 0.150 |
Why?
|
| RAW 264.7 Cells | 4 | 2020 | 18 | 0.150 |
Why?
|
| Glycosides | 2 | 2020 | 13 | 0.150 |
Why?
|
| Reproducibility of Results | 8 | 2017 | 2718 | 0.150 |
Why?
|
| Limonins | 1 | 2018 | 1 | 0.150 |
Why?
|
| Citrus | 1 | 2018 | 3 | 0.150 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2018 | 6 | 0.150 |
Why?
|
| Intestinal Neoplasms | 1 | 2019 | 68 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 87 | 0.140 |
Why?
|
| eIF-2 Kinase | 1 | 2019 | 50 | 0.140 |
Why?
|
| Pancreatitis | 1 | 2019 | 94 | 0.140 |
Why?
|
| Cucurbitaceae | 1 | 2018 | 4 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 398 | 0.140 |
Why?
|
| Eleutherococcus | 1 | 2018 | 1 | 0.140 |
Why?
|
| MPTP Poisoning | 1 | 2018 | 3 | 0.140 |
Why?
|
| Mitochondrial Swelling | 1 | 2018 | 4 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 249 | 0.140 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2019 | 70 | 0.140 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 202 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 188 | 0.140 |
Why?
|
| Receptors, Artificial | 1 | 2018 | 1 | 0.140 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2015 | 41 | 0.140 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 120 | 0.140 |
Why?
|
| Post-Synaptic Density | 1 | 2018 | 7 | 0.140 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2018 | 7 | 0.140 |
Why?
|
| Magnoliopsida | 1 | 2018 | 26 | 0.140 |
Why?
|
| Mesencephalon | 1 | 2018 | 67 | 0.140 |
Why?
|
| Glycosylation | 1 | 2018 | 134 | 0.140 |
Why?
|
| Diterpenes | 1 | 2018 | 24 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1610 | 0.140 |
Why?
|
| Pulsatilla | 1 | 2018 | 1 | 0.140 |
Why?
|
| Models, Molecular | 2 | 2012 | 1354 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2013 | 85 | 0.130 |
Why?
|
| Body Weight | 6 | 2018 | 449 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 501 | 0.130 |
Why?
|
| Drug Interactions | 3 | 2014 | 239 | 0.130 |
Why?
|
| Pneumonia | 1 | 2019 | 193 | 0.130 |
Why?
|
| Pain Management | 1 | 2020 | 180 | 0.130 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 2017 | 3 | 0.130 |
Why?
|
| Myocardium | 1 | 2020 | 570 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 57 | 0.130 |
Why?
|
| Aristolochia | 1 | 2017 | 1 | 0.130 |
Why?
|
| Aristolochic Acids | 1 | 2017 | 1 | 0.130 |
Why?
|
| Honey | 1 | 2017 | 3 | 0.130 |
Why?
|
| Sulindac | 1 | 2017 | 8 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2019 | 257 | 0.130 |
Why?
|
| Berberine | 1 | 2017 | 9 | 0.130 |
Why?
|
| Oxygenases | 1 | 2017 | 17 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2015 | 2544 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 304 | 0.130 |
Why?
|
| Limit of Detection | 4 | 2019 | 21 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 385 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2017 | 94 | 0.130 |
Why?
|
| Phellodendron | 1 | 2016 | 1 | 0.130 |
Why?
|
| Molecular Probes | 1 | 2017 | 37 | 0.120 |
Why?
|
| Drug Therapy, Combination | 3 | 2020 | 759 | 0.120 |
Why?
|
| Skin Absorption | 1 | 2016 | 4 | 0.120 |
Why?
|
| Monoterpenes | 1 | 2016 | 6 | 0.120 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2017 | 56 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2021 | 580 | 0.120 |
Why?
|
| Cardiotonic Agents | 1 | 2017 | 88 | 0.120 |
Why?
|
| North America | 3 | 2014 | 195 | 0.120 |
Why?
|
| Cells, Cultured | 6 | 2021 | 2828 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 102 | 0.120 |
Why?
|
| Catalytic Domain | 2 | 2017 | 162 | 0.120 |
Why?
|
| Curcuma | 1 | 2015 | 2 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 147 | 0.120 |
Why?
|
| Skin | 2 | 2016 | 576 | 0.120 |
Why?
|
| Solvents | 3 | 2022 | 91 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2014 | 201 | 0.120 |
Why?
|
| Seasons | 1 | 2017 | 240 | 0.120 |
Why?
|
| Pyrazines | 1 | 2016 | 93 | 0.120 |
Why?
|
| Molecular Conformation | 1 | 2016 | 111 | 0.120 |
Why?
|
| Vacuoles | 2 | 2013 | 48 | 0.120 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 77 | 0.110 |
Why?
|
| Abrus | 1 | 2015 | 1 | 0.110 |
Why?
|
| Receptor Cross-Talk | 1 | 2015 | 33 | 0.110 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2015 | 44 | 0.110 |
Why?
|
| Microdialysis | 2 | 2012 | 23 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 111 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 1516 | 0.110 |
Why?
|
| Foeniculum | 1 | 2015 | 1 | 0.110 |
Why?
|
| Anisoles | 1 | 2015 | 5 | 0.110 |
Why?
|
| Dietary Fats | 2 | 2015 | 135 | 0.110 |
Why?
|
| Oils, Volatile | 1 | 2014 | 1 | 0.110 |
Why?
|
| Chromatography, Supercritical Fluid | 1 | 2014 | 1 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2019 | 456 | 0.110 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 160 | 0.110 |
Why?
|
| Canada | 2 | 2014 | 194 | 0.110 |
Why?
|
| Chromatography, Micellar Electrokinetic Capillary | 1 | 2014 | 2 | 0.110 |
Why?
|
| China | 2 | 2014 | 264 | 0.110 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 25 | 0.110 |
Why?
|
| Allopurinol | 1 | 2015 | 77 | 0.110 |
Why?
|
| Gastrins | 1 | 2014 | 15 | 0.110 |
Why?
|
| Uricosuric Agents | 1 | 2014 | 11 | 0.110 |
Why?
|
| Picrates | 4 | 2017 | 12 | 0.110 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 2021 | 39 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 740 | 0.110 |
Why?
|
| Anticholesteremic Agents | 1 | 2016 | 154 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2021 | 696 | 0.100 |
Why?
|
| Enteritis | 1 | 2014 | 23 | 0.100 |
Why?
|
| Biphenyl Compounds | 4 | 2017 | 60 | 0.100 |
Why?
|
| Metformin | 1 | 2015 | 125 | 0.100 |
Why?
|
| Amino Acids | 3 | 2021 | 246 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2014 | 42 | 0.100 |
Why?
|
| Chick Embryo | 5 | 2017 | 176 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 556 | 0.100 |
Why?
|
| Diet | 1 | 2016 | 460 | 0.100 |
Why?
|
| Genistein | 1 | 2013 | 16 | 0.100 |
Why?
|
| Steroids | 1 | 2014 | 167 | 0.100 |
Why?
|
| Crocus | 1 | 2013 | 3 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 193 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 49 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 87 | 0.100 |
Why?
|
| Iridoids | 1 | 2013 | 2 | 0.100 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2013 | 3 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 100 | 0.100 |
Why?
|
| Cyclin B1 | 1 | 2013 | 16 | 0.100 |
Why?
|
| Microbiota | 1 | 2018 | 425 | 0.100 |
Why?
|
| Superoxide Dismutase | 3 | 2022 | 155 | 0.100 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2013 | 64 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2014 | 127 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2017 | 66 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 203 | 0.090 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2013 | 165 | 0.090 |
Why?
|
| Corydalis | 2 | 2020 | 4 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 196 | 0.090 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 42 | 0.090 |
Why?
|
| Adult | 9 | 2020 | 27955 | 0.090 |
Why?
|
| Intestinal Mucosa | 3 | 2014 | 824 | 0.090 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2012 | 99 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 373 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 98 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2012 | 83 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 2020 | 300 | 0.090 |
Why?
|
| Herb-Drug Interactions | 1 | 2011 | 5 | 0.090 |
Why?
|
| Injections, Intraperitoneal | 3 | 2009 | 102 | 0.090 |
Why?
|
| Hypoxia | 1 | 2017 | 675 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2015 | 1119 | 0.090 |
Why?
|
| Rhizome | 2 | 2009 | 7 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2011 | 117 | 0.090 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2017 | 146 | 0.090 |
Why?
|
| Quality of Life | 4 | 2023 | 1783 | 0.090 |
Why?
|
| Neurons | 2 | 2017 | 1575 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 836 | 0.090 |
Why?
|
| Autophagy | 3 | 2019 | 172 | 0.090 |
Why?
|
| Proanthocyanidins | 1 | 2011 | 12 | 0.080 |
Why?
|
| Camptothecin | 1 | 2012 | 196 | 0.080 |
Why?
|
| Pyridines | 1 | 2013 | 302 | 0.080 |
Why?
|
| Mice, Mutant Strains | 3 | 2017 | 219 | 0.080 |
Why?
|
| Cyclosporine | 1 | 2011 | 241 | 0.080 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2020 | 70 | 0.080 |
Why?
|
| Linear Models | 3 | 2017 | 414 | 0.080 |
Why?
|
| Stroke | 1 | 2019 | 1079 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 885 | 0.080 |
Why?
|
| Glucuronates | 1 | 2010 | 21 | 0.080 |
Why?
|
| Apigenin | 1 | 2010 | 8 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2011 | 523 | 0.080 |
Why?
|
| Metagenome | 1 | 2011 | 116 | 0.080 |
Why?
|
| Tablets | 1 | 2011 | 127 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 639 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2019 | 1130 | 0.080 |
Why?
|
| Magnetic Phenomena | 2 | 2020 | 4 | 0.080 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2009 | 27 | 0.080 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 31 | 0.080 |
Why?
|
| Adiposity | 1 | 2009 | 76 | 0.070 |
Why?
|
| Araliaceae | 1 | 2009 | 2 | 0.070 |
Why?
|
| Leptin | 1 | 2009 | 100 | 0.070 |
Why?
|
| Binding Sites | 1 | 2012 | 1128 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 457 | 0.070 |
Why?
|
| Polymerization | 2 | 2019 | 36 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 2 | 2015 | 441 | 0.070 |
Why?
|
| Surface Properties | 2 | 2020 | 126 | 0.070 |
Why?
|
| Species Specificity | 2 | 2014 | 683 | 0.070 |
Why?
|
| Fractals | 2 | 2020 | 41 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 1923 | 0.070 |
Why?
|
| Anthraquinones | 2 | 2022 | 7 | 0.070 |
Why?
|
| Heating | 1 | 2008 | 17 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2011 | 506 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 589 | 0.070 |
Why?
|
| Weight Gain | 1 | 2009 | 128 | 0.070 |
Why?
|
| Solubility | 2 | 2020 | 186 | 0.070 |
Why?
|
| Protein Binding | 1 | 2012 | 1528 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 1723 | 0.070 |
Why?
|
| Fatty Acids | 2 | 2021 | 145 | 0.070 |
Why?
|
| Oxidants | 4 | 2012 | 86 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 1389 | 0.070 |
Why?
|
| Magnetics | 2 | 2018 | 41 | 0.070 |
Why?
|
| Weight Loss | 1 | 2009 | 234 | 0.070 |
Why?
|
| Hydrogen Peroxide | 4 | 2012 | 164 | 0.070 |
Why?
|
| HIV Protease Inhibitors | 1 | 2007 | 21 | 0.070 |
Why?
|
| Ritonavir | 1 | 2007 | 13 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1260 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2021 | 101 | 0.060 |
Why?
|
| Liver | 3 | 2018 | 1207 | 0.060 |
Why?
|
| Endothelins | 2 | 2017 | 26 | 0.060 |
Why?
|
| Freund's Adjuvant | 2 | 2019 | 25 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2020 | 89 | 0.060 |
Why?
|
| Camellia sinensis | 1 | 2007 | 6 | 0.060 |
Why?
|
| Diet, Western | 2 | 2017 | 45 | 0.060 |
Why?
|
| Kidney | 3 | 2018 | 1110 | 0.060 |
Why?
|
| Double-Blind Method | 4 | 2015 | 1731 | 0.060 |
Why?
|
| Carrageenan | 2 | 2018 | 9 | 0.060 |
Why?
|
| Cell Shape | 1 | 2006 | 50 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 826 | 0.060 |
Why?
|
| Triglycerides | 2 | 2017 | 231 | 0.060 |
Why?
|
| Murraya | 1 | 2006 | 2 | 0.060 |
Why?
|
| Zanthoxylum | 2 | 2016 | 9 | 0.060 |
Why?
|
| Zingiberaceae | 2 | 2016 | 10 | 0.060 |
Why?
|
| Administration, Cutaneous | 2 | 2016 | 61 | 0.060 |
Why?
|
| Cell Division | 1 | 2006 | 690 | 0.060 |
Why?
|
| Glucose Tolerance Test | 3 | 2014 | 233 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 416 | 0.060 |
Why?
|
| Medicine, Traditional | 2 | 2016 | 8 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2018 | 691 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2005 | 335 | 0.060 |
Why?
|
| Angelica | 1 | 2004 | 2 | 0.050 |
Why?
|
| Organic Anion Transport Protein 1 | 2 | 2015 | 4 | 0.050 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2015 | 8 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2015 | 9108 | 0.050 |
Why?
|
| Organic Anion Transporters | 2 | 2015 | 26 | 0.050 |
Why?
|
| United States | 3 | 2014 | 7645 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 528 | 0.050 |
Why?
|
| Uric Acid | 2 | 2015 | 137 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2018 | 379 | 0.050 |
Why?
|
| Mice, Obese | 3 | 2009 | 49 | 0.050 |
Why?
|
| Swine | 2 | 2016 | 587 | 0.050 |
Why?
|
| Receptors, CXCR6 | 1 | 2022 | 6 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 890 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2022 | 22 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2022 | 54 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 3 | 2012 | 324 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2022 | 35 | 0.050 |
Why?
|
| Propionates | 1 | 2022 | 31 | 0.050 |
Why?
|
| Oleanolic Acid | 1 | 2022 | 6 | 0.050 |
Why?
|
| Oxalic Acid | 1 | 2022 | 8 | 0.050 |
Why?
|
| Medicine, Tibetan Traditional | 1 | 2021 | 1 | 0.040 |
Why?
|
| Hordeum | 1 | 2021 | 10 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2014 | 672 | 0.040 |
Why?
|
| Tibet | 1 | 2021 | 22 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2022 | 93 | 0.040 |
Why?
|
| DNA | 1 | 2007 | 1260 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2021 | 102 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2022 | 167 | 0.040 |
Why?
|
| Transferrin | 1 | 2021 | 19 | 0.040 |
Why?
|
| Time Factors | 4 | 2014 | 5406 | 0.040 |
Why?
|
| Fructose | 1 | 2021 | 36 | 0.040 |
Why?
|
| Catalase | 2 | 2015 | 46 | 0.040 |
Why?
|
| Vegetables | 1 | 2022 | 50 | 0.040 |
Why?
|
| Trigeminal Nerve | 1 | 2021 | 14 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 293 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 281 | 0.040 |
Why?
|
| G1 Phase | 2 | 2012 | 64 | 0.040 |
Why?
|
| Middle Aged | 6 | 2018 | 27621 | 0.040 |
Why?
|
| Epitopes | 1 | 2021 | 249 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2020 | 29 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 464 | 0.040 |
Why?
|
| Epigenomics | 1 | 2021 | 109 | 0.040 |
Why?
|
| Ethanol | 2 | 2015 | 273 | 0.040 |
Why?
|
| Aconitum | 1 | 2020 | 3 | 0.040 |
Why?
|
| Risk | 2 | 2013 | 657 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 258 | 0.040 |
Why?
|
| Vinyl Compounds | 1 | 2019 | 7 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2020 | 63 | 0.040 |
Why?
|
| Sulfates | 1 | 2019 | 38 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2019 | 81 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 126 | 0.040 |
Why?
|
| Acrylamides | 1 | 2019 | 34 | 0.040 |
Why?
|
| Boronic Acids | 1 | 2019 | 55 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2019 | 18 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2019 | 31 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2019 | 77 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2019 | 290 | 0.040 |
Why?
|
| Carbon | 1 | 2019 | 96 | 0.040 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2019 | 29 | 0.040 |
Why?
|
| Paclitaxel | 1 | 2020 | 479 | 0.040 |
Why?
|
| Trifolium | 1 | 2018 | 1 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2010 | 775 | 0.040 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 178 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2013 | 317 | 0.030 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2018 | 20 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2018 | 71 | 0.030 |
Why?
|
| Stilbenes | 1 | 2018 | 26 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2018 | 111 | 0.030 |
Why?
|
| Models, Biological | 2 | 2018 | 1768 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 278 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1980 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2017 | 85 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 168 | 0.030 |
Why?
|
| Trigeminal Nuclei | 1 | 2017 | 3 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 141 | 0.030 |
Why?
|
| Porosity | 1 | 2017 | 64 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2017 | 22 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2017 | 127 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 208 | 0.030 |
Why?
|
| Quality Control | 1 | 2017 | 123 | 0.030 |
Why?
|
| Inactivation, Metabolic | 1 | 2016 | 9 | 0.030 |
Why?
|
| Rutaceae | 1 | 2016 | 2 | 0.030 |
Why?
|
| Omeprazole | 1 | 2016 | 11 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 2368 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 169 | 0.030 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2016 | 8 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 276 | 0.030 |
Why?
|
| Kaolin | 2 | 2007 | 9 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 146 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2017 | 119 | 0.030 |
Why?
|
| Analgesia | 1 | 2017 | 64 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2016 | 37 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 148 | 0.030 |
Why?
|
| Wound Healing | 1 | 2018 | 373 | 0.030 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 3 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 115 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2016 | 70 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2006 | 39 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 490 | 0.030 |
Why?
|
| Indoles | 1 | 2018 | 301 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2019 | 752 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 265 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 30 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 478 | 0.030 |
Why?
|
| Peroxidase | 1 | 2015 | 54 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2015 | 75 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2016 | 173 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2016 | 87 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2015 | 33 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 105 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1912 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 700 | 0.030 |
Why?
|
| Gastric Acid | 1 | 2014 | 5 | 0.030 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2014 | 3 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 660 | 0.030 |
Why?
|
| Oxonic Acid | 1 | 2014 | 8 | 0.030 |
Why?
|
| Ligation | 1 | 2014 | 54 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 246 | 0.030 |
Why?
|
| Mucins | 1 | 2014 | 40 | 0.030 |
Why?
|
| Xanthine Oxidase | 1 | 2014 | 25 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2014 | 64 | 0.030 |
Why?
|
| Ubiquitinated Proteins | 1 | 2014 | 4 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 25 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2014 | 25 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2014 | 26 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 24 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 84 | 0.030 |
Why?
|
| Propanols | 1 | 2014 | 3 | 0.030 |
Why?
|
| Calibration | 1 | 2014 | 107 | 0.030 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2014 | 41 | 0.030 |
Why?
|
| Pressure | 1 | 2014 | 166 | 0.030 |
Why?
|
| Triterpenes | 1 | 2014 | 8 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 76 | 0.030 |
Why?
|
| Lignans | 1 | 2014 | 6 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2014 | 135 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2017 | 390 | 0.030 |
Why?
|
| Acetylation | 1 | 2014 | 149 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 146 | 0.030 |
Why?
|
| Ankle Joint | 1 | 2014 | 59 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 99 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 254 | 0.020 |
Why?
|
| Liquid-Liquid Extraction | 1 | 2013 | 1 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 361 | 0.020 |
Why?
|
| Salvia miltiorrhiza | 1 | 2013 | 3 | 0.020 |
Why?
|
| Pre-B-Cell Leukemia Transcription Factor 1 | 1 | 2012 | 5 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 57 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2014 | 196 | 0.020 |
Why?
|
| Knee Joint | 1 | 2014 | 161 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 374 | 0.020 |
Why?
|
| Life Style | 1 | 2014 | 183 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 152 | 0.020 |
Why?
|
| Anthracenes | 1 | 2012 | 13 | 0.020 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 77 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 69 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2012 | 20 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2012 | 51 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 1866 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2459 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 774 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 168 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 192 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 990 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 281 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 166 | 0.020 |
Why?
|
| Urine | 1 | 2012 | 94 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 264 | 0.020 |
Why?
|
| Insulin | 2 | 2008 | 1185 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2121 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2010 | 25 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2010 | 32 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 555 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 52 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 83 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 688 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2010 | 73 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 101 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2011 | 131 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2009 | 41 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1531 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 654 | 0.020 |
Why?
|
| Naloxone | 1 | 2009 | 72 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 367 | 0.020 |
Why?
|
| Eating | 1 | 2009 | 162 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 519 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 603 | 0.020 |
Why?
|
| Gastric Emptying | 1 | 2007 | 26 | 0.020 |
Why?
|
| Hydroxyl Radical | 1 | 2007 | 36 | 0.020 |
Why?
|
| Hydrazines | 1 | 2007 | 33 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2009 | 299 | 0.020 |
Why?
|
| CD56 Antigen | 1 | 2007 | 18 | 0.020 |
Why?
|
| Thirst | 1 | 2007 | 19 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 392 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 1102 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1918 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1233 | 0.020 |
Why?
|
| Superoxides | 1 | 2007 | 75 | 0.020 |
Why?
|
| Chlorogenic Acid | 1 | 2006 | 3 | 0.020 |
Why?
|
| Caffeic Acids | 1 | 2006 | 5 | 0.020 |
Why?
|
| Uncoupling Agents | 1 | 2006 | 15 | 0.020 |
Why?
|
| Antimycin A | 1 | 2006 | 13 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2006 | 200 | 0.010 |
Why?
|
| Fatigue | 1 | 2007 | 181 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 410 | 0.010 |
Why?
|
| Antidiarrheals | 1 | 2005 | 14 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 281 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2012 | 1690 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2004 | 159 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 390 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 6938 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 9610 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 884 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 474 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 4266 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 20469 | 0.010 |
Why?
|